Replies to post #66003 on NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Anybody can ride an obvious wave on a sunny day. Everyone long biotech as it ran up into bubble territory, even off horrible DD, looked like a smarty pants. Til it burst.

Buying even more NWBO here? Do you advise buying, holding or selling NWBO at these prices?

TIA

[maverick_1]

This small capital raise of $3.7 MLN with TWO NEW INST'L Investors IMPLIES:

1)It would appear that there is No known/pending issues that clashes with PH3 trials with the FDA despite the posts: It would have happened ALREADY but:This has been Going on for 11 MONTHS!
2) ONLY TWO Biotec savants dealing with the above issue would INVEST and it would NOT be a material position but COULD BE MEANINGFUL to their future portfolio results!
3) CEO LP believes it is sufficient before Bigger News
4) CEO LP apparently chose Charden Capital because of Gbola Amusa, MD, CFA who clearly has the CLOUT both in the US and Europe even with sub $1 stocks to DEAL with NEFARIOUS NETWORK of MANIPULATORS.
5) As for those TWO NEW INST'L Investors: Just take a simple look @ this other issue I own and it should be readily apparent!:
http://www.nasdaq.com/symbol/mstx/institutional-holdings
6) Another reminder one should have already done an extensive Google on Les Goldman to understand what he had achieved in his distinguished career and why he chose to be with NWBO along with providing bridge loans when needed.

Pursuing and doting on what's uncovered from the points above may give one some further clarity beyond their nose.

CROW all you like: getting closer.

Tenacious CEO Linda Powers MOVING ON and going for yet another dip, round tripping from The Ashes to the expected Phoenix.

At this juncture separating the Boys from the Men in this long brutal endeavor.

Was comforted by catching up and uncovering RKMatters clairvoyant discoveries mid May.

Not losing any sleep given my exit and re-entry points.

[maverick_1]

At some point would think adding NWBO to Chardan Capital's universe of stock coverage will take place (think of all the institutional contacts he has generated with his stock picking record in both the US and Europe)

COVERAGE UNIVERSE of Charden Capital:
chardancm.com/sites/all/modules/filefield/icons/protocons/16x16/mimetypes/application-pdf.png

BTW worth re reading that post highlighting:

Accomplishments of
Gbola Amusa, MD, CFA
Managing Director, Director of Research, Head of Healthcare Research at Chardan Capital Markets

[pgsd]

2)Late 2015 post interchange with ReadyforWHAT on Neil Woodford's corporate charter for his two funds which supports #1

Interesting that some of his global positioning also included Neil Woodford's two funds.